Literature DB >> 17913395

Prescription opioid use, misuse, and diversion among street drug users in New York City.

W Rees Davis1, Bruce D Johnson.   

Abstract

OBJECTIVE: The use of heroin, cocaine, and other drugs is well researched in New York City, but prescription opioids (POs) have been overlooked. This study documents patterns of PO use, misuse, and diversion among street drug users, and begins to indicate how drug culture practices interact with the legitimate therapeutic goals of PO prescriptions (e.g. pain management).
METHODS: Staff completed interviews inquiring about the reasons for use of POs and illicit drugs with 586 street drug users. Ethnographers wrote extensive field notes about subjects' complex patterns of PO use.
RESULTS: Methadone was used (71.9%) and sold (64.7%) at a higher level than OxyContin, Vicodin, and Percocet, used by between 34% and 38% of the users and sold by between 28% and 41% of the sellers. Recent PO use is associated with the recency of using heroin and cocaine (p<.001). Half of the heroin/cocaine sellers sold POs, and one quarter of the PO sellers only sold POs. Subjects were classified into four groups by whether they diverted POs or used POs to relieve pain or withdrawal rather than for euphoria. This classification was associated with frequency of PO use, whether POs were obtained from doctors/pharmacies or from drug dealers and family members, and those mostly likely to use POs for pain and withdrawal.
CONCLUSIONS: POs are an important component of street drug users' drug-taking regimes, especially those who are Physically Ill Chemical Abusers (PICA). Future research is needed to model PO use, misuse, and diversion among this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913395      PMCID: PMC2317747          DOI: 10.1016/j.drugalcdep.2007.08.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  13 in total

1.  Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London.

Authors:  J Fountain; J Strang; M Gossop; M Farrell; P Griffiths
Journal:  Addiction       Date:  2000-03       Impact factor: 6.526

2.  Risk factors associated with problem use of prescription drugs.

Authors:  Linda Simoni-Wastila; Gail Strickler
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

3.  Socioeconomic marginality and health services utilization among Central Harlem substance users.

Authors:  Peter H Van Ness; W Rees Davis; Bruce D Johnson
Journal:  Subst Use Misuse       Date:  2004-01       Impact factor: 2.164

4.  Nonmedical use of prescription opioids among U.S. college students: prevalence and correlates from a national survey.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd; John R Knight; Henry Wechsler
Journal:  Addict Behav       Date:  2005-05       Impact factor: 3.913

5.  "We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics.

Authors:  R S Morrison; S Wallenstein; D K Natale; R S Senzel; L L Huang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 6.  Addiction: part II. Identification and management of the drug-seeking patient.

Authors:  L P Longo; T Parran; B Johnson; W Kinsey
Journal:  Am Fam Physician       Date:  2000-04-15       Impact factor: 3.292

7.  Prescription opioid abuse among enrollees into methadone maintenance treatment.

Authors:  Andrew Rosenblum; Mark Parrino; Sidney H Schnoll; Chunki Fong; Carleen Maxwell; Charles M Cleland; Stephen Magura; J David Haddox
Journal:  Drug Alcohol Depend       Date:  2007-03-26       Impact factor: 4.492

8.  Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.

Authors:  Edward Michna; Edgar L Ross; Wilfred L Hynes; Srdjan S Nedeljkovic; Sharonah Soumekh; David Janfaza; Diane Palombi; Robert N Jamison
Journal:  J Pain Symptom Manage       Date:  2004-09       Impact factor: 3.612

9.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 10.  Identifying the drug seeker: the advanced practice nurse's role in managing prescription drug abuse.

Authors:  Annie M Gerhardt
Journal:  J Am Acad Nurse Pract       Date:  2004-06
View more
  60 in total

1.  Patterns of prescription medication diversion among drug dealers.

Authors:  Khary K Rigg; Steven P Kurtz; Hilary L Surratt
Journal:  Drugs (Abingdon Engl)       Date:  2012

2.  Heroin use onset among nonmedical prescription opioid users in the club scene.

Authors:  Hilary L Surratt; Steven P Kurtz; Mance Buttram; Maria A Levi-Minzi; Maria E Pagano; Theodore J Cicero
Journal:  Drug Alcohol Depend       Date:  2017-07-26       Impact factor: 4.492

Review 3.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

Review 4.  Update in addiction medicine for the primary care clinician.

Authors:  Adam J Gordon; David A Fiellin; Peter D Friedmann; Marc N Gourevitch; Kevin L Kraemer; Julia H Arnsten; Richard Saitz
Journal:  J Gen Intern Med       Date:  2008-10-02       Impact factor: 5.128

5.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

6.  Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Authors:  Ning-Sheng Cai; César Quiroz; Jordi Bonaventura; Alessandro Bonifazi; Thomas O Cole; Julia Purks; Amy S Billing; Ebonie Massey; Michael Wagner; Eric D Wish; Xavier Guitart; William Rea; Sherry Lam; Estefanía Moreno; Verònica Casadó-Anguera; Aaron D Greenblatt; Arthur E Jacobson; Kenner C Rice; Vicent Casadó; Amy H Newman; John W Winkelman; Michael Michaelides; Eric Weintraub; Nora D Volkow; Annabelle M Belcher; Sergi Ferré
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

7.  Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.

Authors:  Becky L Genberg; Mirinda Gillespie; Charles R Schuster; Chris-Ellyn Johanson; Jacquie Astemborski; Gregory D Kirk; David Vlahov; Shruti H Mehta
Journal:  Addict Behav       Date:  2013-08-17       Impact factor: 3.913

8.  I heard about it from a friend: assessing interest in buprenorphine treatment.

Authors:  Aaron D Fox; Pooja A Shah; Nancy L Sohler; Carolina M Lopez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

9.  Factors associated with illicit methadone injecting in a Canadian setting.

Authors:  Devin Tucker; M-J Milloy; Kanna Hayashi; Paul Nguyen; Thomas Kerr; Evan Wood
Journal:  Am J Addict       Date:  2015-08-18

10.  Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study.

Authors:  Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin
Journal:  Am J Addict       Date:  2013 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.